Literature DB >> 21226590

Induced pluripotent stem cells in long-QT syndrome.

Shigeo Masuda, Yutaka Hanazono.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21226590     DOI： 10.1056/NEJMc1012529

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Optimizing dynamic interactions between a cardiac patch and inflammatory host cells.

Authors:  Donald O Freytes; Laura Santambrogio; Gordana Vunjak-Novakovic
Journal:  Cells Tissues Organs       Date:  2011-10-12       Impact factor: 2.481

2.  Emerging innovation towards safety in the clinical application of ESCs and iPSCs.

Authors:  Shigeo Masuda; Shigeru Miyagawa; Satsuki Fukushima; Nagako Sougawa; Emiko Ito; Maki Takeda; Atsuhiro Saito; Yoshiki Sawa
Journal:  Nat Rev Cardiol       Date:  2014-08-05       Impact factor: 32.419

3.  Expandable progenitors from induced pluripotent stem cells.

Authors:  Shigeo Masuda; Shigeru Miyagawa; Satsuki Fukushima; Terumi Nakamura; Maaz Asher Khurram; Tsuyoshi Ishikawa; Atsuhiro Saito; Yoshiki Sawa
Journal:  Nat Rev Cardiol       Date:  2016-08-19       Impact factor: 32.419

4.  A Simplified In Vitro Teratoma Assay for Pluripotent Stem Cells Injected Into Rodent Fetal Organs.

Authors:  Shigeo Masuda; Takashi Yokoo; Naomi Sugimoto; Masako Doi; Shuh-Hei Fujishiro; Kengo Takeuchi; Eiji Kobayashi; Yutaka Hanazono
Journal:  Cell Med       Date:  2012-05-08

5.  Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics.

Authors:  Cecile Terrenoire; Kai Wang; Kelvin W Chan Tung; Wendy K Chung; Robert H Pass; Jonathan T Lu; Jyh-Chang Jean; Amel Omari; Kevin J Sampson; Darrell N Kotton; Gordon Keller; Robert S Kass
Journal:  J Gen Physiol       Date:  2013-01       Impact factor: 4.086
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.